Literature DB >> 15199319

Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit.

Enrique Casalino1, Michel Wolff, Philippe Ravaud, Christophe Choquet, Fabrice Bruneel, Bernard Regnier.   

Abstract

BACKGROUND: Several studies found increased survival times and decreased hospitalization rates since the introduction of highly active antiretroviral therapy (HAART).
OBJECTIVE: To examine the impact of HAART on admission patterns and survival of HIV-infected patients admitted to an intensive care unit (ICU).
DESIGN: Prospective observational cohort study. SETTING AND
SUBJECTS: All HIV-infected patients admitted from 1 January 1995 to 30 June 1999, to an infectious diseases ICU located in Paris. MAIN OUTCOME MEASURES: ICU utilization and admission patterns, and survival.
RESULTS: A total of 426 HIV-related admissions were included. Sepsis increased from 16.3% to 22.6% from the pre- to the post-HAART era, whereas AIDS-related admissions decreased from 57.7% to 37% (P < 0.05). No significant difference in ICU utilization was found. In both periods, half of the patients were not on antiretroviral treatment at ICU admission. In-ICU mortality was 23%, without significant difference between the study periods. By multivariable analysis, in-ICU mortality was significantly associated with SAPS II > 40, Omega score > 75 and mechanical ventilation; and long-term survival with admission in the HAART era and AIDS at ICU admission. Cumulative survival rates after ICU discharge were 85.3% and 70.8% after 12 and 24 months, respectively.
CONCLUSIONS: HAART had little impact on ICU utilization by HIV-infected patients. After the introduction of HAART AIDS-related conditions decreased and sepsis increased as reasons for ICU admission. Whereas ICU survival was dependent on usual prognostic markers, long-term survival was clearly dependent on HIV disease stage and HAART availability. In both study periods, at least a half of the HIV infected patients were not on anti-retroviral treatment at the time of ICU admission.

Entities:  

Mesh:

Year:  2004        PMID: 15199319     DOI: 10.1097/01.aids.0000131301.55204.a7

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  50 in total

1.  [Treatment of neuro-AIDS on a neurological intensive care unit: epidemiology and predictors of outcome].

Authors:  O Braicks; K Anneken; D Reichelt; W R Schäbitz; R Dziewas; S Evers; I W Husstedt
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

2.  HIV Infection and Severe Sepsis: A Bitter Pill to Swallow.

Authors:  Matthew R Gingo; Alison Morris
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

3.  Prevalence and Predictors of Hospitalizations Among HIV-Infected and At-Risk HIV-Uninfected Women.

Authors:  Anna L Hotton; Kathleen M Weber; Ronald C Hershow; Kathryn Anastos; Peter Bacchetti; Elizabeth T Golub; Deborah Gustafson; Alexandra M Levine; Mary Young; Mardge H Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

4.  Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy.

Authors:  Jared A Greenberg; Jeffrey L Lennox; Greg S Martin
Journal:  J Crit Care       Date:  2011-10-26       Impact factor: 3.425

5.  Hospitalization risk following initiation of highly active antiretroviral therapy.

Authors:  S A Berry; Y C Manabe; R D Moore; K A Gebo
Journal:  HIV Med       Date:  2009-12-08       Impact factor: 3.180

6.  Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era.

Authors:  Isaline Coquet; Juliette Pavie; Pierre Palmer; François Barbier; Stéphane Legriel; Julien Mayaux; Jean Michel Molina; Benoît Schlemmer; Elie Azoulay
Journal:  Crit Care       Date:  2010-06-09       Impact factor: 9.097

7.  Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients.

Authors:  André M Japiassú; Rodrigo T Amâncio; Emerson C Mesquita; Denise M Medeiros; Helena B Bernal; Estevão P Nunes; Paula M Luz; Beatriz Grinsztejn; Fernando A Bozza
Journal:  Crit Care       Date:  2010-08-10       Impact factor: 9.097

Review 8.  Critical care of persons infected with the human immunodeficiency virus.

Authors:  Anuradha Ganesan; Henry Masur
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

9.  Improved Outcomes in Critically Ill Patients With AIDS: How Does This Trend Continue?

Authors:  Daniel A Sweeney; Kevan Akrami; Atul Malhotra
Journal:  Crit Care Med       Date:  2016-02       Impact factor: 7.598

10.  Development of a nursing intervention to facilitate optimal antiretroviral-treatment taking among people living with HIV.

Authors:  Pilar Ramirez-Garcia; José Côté
Journal:  BMC Health Serv Res       Date:  2009-07-03       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.